Startups channel feed – Endpoints News

Startups channel feed

Immunology biotech Alumis secures $250M in shrunken IPO

10 months ago

One Medical CEO-turned-VC wants startups that are 'disruptive from within the ecosystem'

10 months ago

Exclusive: To develop better cell therapies for solid tumors, a new startup plans to test hundreds of them at once

10 months ago

Longevity investors look to add $200M to the table with new growth fund

10 months ago

Maze spins its ALS antisense program into a secretive new company

10 months ago

Alexis Borisy and Zach Weinberg's Curie.Bio secures $380M to support portfolio's Series A rounds

10 months ago

Exclusive: Cityblock Health investors buy employee shares in tender offer

10 months ago

New cancer biotech emerges from Stanford research, with help of Nobel laureate Carolyn Bertozzi

10 months ago

Ex-Meta scientists launch EvolutionaryScale with $142M seed round, unveiling next-gen AI model for protein design

10 months ago

Can mRNA be harnessed for gene insertion? Moderna's former chief medical officer has $82M to find out

10 months ago

Schizophrenia biotech LB Pharmaceuticals eyes near-term IPO filing — source

10 months ago

Alumis aims for this year’s third-largest biotech IPO as it readies for Phase 3

10 months ago

Tectonic enters public markets in one of few biotech reverse mergers this year

10 months ago

Gilead tested an antibody many times. A small biotech salvages it, with $40M and ‘conviction’ elsewhere

10 months ago

Roche strikes neuro-focused partnership with RNA exon editing startup, worth as much as $1.8B

10 months ago

As it deepens immunology bets, Sanofi inks small molecule pact with Belharra

10 months ago

Marea Therapeutics launches with $190M, seeing a 'fixable problem' in a neglected cardiometabolic target

10 months ago

Life sciences investor Decheng Capital targets $700M for fifth fund

10 months ago

Telehealth startup Done's execs arrested and charged for alleged Adderall scheme, DOJ says

11 months ago

Is $13B Devoted Health succeeding where other insurance upstarts have failed?

11 months ago

'Speed is everything': Versant-backed immunology startup raises $125M with plans for quick data

11 months ago

Exclusive: Former Merck scientists raise $85M to map and drug protein interactions in cancer and autoimmune disease

11 months ago

Foresite Capital closes $900M sixth fund, backing the likes of Xaira and IPO hopeful Alumis

11 months ago

Verily gets into the GLP-1 business with new program to manage cardiac and metabolic conditions

11 months ago

First page Previous page 13 14 151617 18 19 Next page Last page